Liraglutide ameliorates nonalcoholic fatty liver disease in diabetic mice via the IRS2/PI3K/Akt signaling pathway

Purpose: High prevalence of nonalcoholic fatty liver disease (NAFLD) among patients with type 2 diabetes has implicated the role of hepatic insulin resistance (IR) in the diseases. To better understand the underlying mechanism, we have evaluated the pathophysiological effects of Liraglutide on NAFLD...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Pijian, Liang, Yuzhen, Luo, Yunchen, Li, Zhengming, Wen, Yumei, Shen, Jing, Li, Ruwen, Zheng, Hua, Gu, Harvest F, Xia, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614831/
https://www.ncbi.nlm.nih.gov/pubmed/31308717
http://dx.doi.org/10.2147/DMSO.S206867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614831/
https://www.ncbi.nlm.nih.gov/pubmed/31308717
http://dx.doi.org/10.2147/DMSO.S206867

Ejemplares similares